tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

STOK Stock Latest News

Stoke Therapeutics negative reaction after STK-001 update overdone, says Chardan
The FlyStoke Therapeutics negative reaction after STK-001 update overdone, says Chardan
11d ago
STOK
Stoke Therapeutics Gains Regulatory Alignment for Phase 3 Study
PremiumCompany Announcements
Stoke Therapeutics Gains Regulatory Alignment for Phase 3 Study
11d ago
8K
STOK
Stoke Therapeutics finalizes EMPEROR study program with regulatory agencies
PremiumThe Fly
Stoke Therapeutics finalizes EMPEROR study program with regulatory agencies
11d ago
STOK
GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth
PremiumMarket News
GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth
18d ago
WGS
BIIB
Stoke Therapeutics initiated with a Buy at Chardan
PremiumThe Fly
Stoke Therapeutics initiated with a Buy at Chardan
29d ago
STOK
Stoke Therapeutics Gains FDA Breakthrough for Epilepsy Drug
PremiumCompany AnnouncementsStoke Therapeutics Gains FDA Breakthrough for Epilepsy Drug
1M ago
8K
STOK
Stoke reports ‘substantial’ reductions in seizure frequency with zorevunersen
Premium
The Fly
Stoke reports ‘substantial’ reductions in seizure frequency with zorevunersen
1M ago
STOK
Stoke Therapeutics zorevunersen receives Breakthrough Therapy Designation
Premium
The Fly
Stoke Therapeutics zorevunersen receives Breakthrough Therapy Designation
2M ago
STOK
Stoke Therapeutics Reports Q3 Results, Focuses on Phase 3 Study
PremiumCompany Announcements
Stoke Therapeutics Reports Q3 Results, Focuses on Phase 3 Study
2M ago
STOK
Stoke Therapeutics assumed with an Outperform at Leerink
PremiumThe Fly
Stoke Therapeutics assumed with an Outperform at Leerink
3M ago
STOK
Stoke Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Stoke Therapeutics files automatic mixed securities shelf
3M ago
STOK
3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
4M ago
INSM
ROIV
Stoke Therapeutics presents Zorevunersen data at EEC
PremiumThe FlyStoke Therapeutics presents Zorevunersen data at EEC
4M ago
STOK
Stoke Therapeutics (STOK) Stock Surges on Potential Genetic Treatment Breakthrough
Premium
Market News
Stoke Therapeutics (STOK) Stock Surges on Potential Genetic Treatment Breakthrough
4M ago
ACAD
STOK
Stoke Therapeutics appoints Eric Olson Chief Business Officer.
Premium
The Fly
Stoke Therapeutics appoints Eric Olson Chief Business Officer.
5M ago
STOK
Stoke Therapeutics reports Q2 EPS (46c), consensus (56c)
PremiumThe Fly
Stoke Therapeutics reports Q2 EPS (46c), consensus (56c)
5M ago
STOK
Stoke Therapeutics (STOK) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Stoke Therapeutics (STOK) Q2 Earnings Cheat Sheet
6M ago
STOK
Stoke Therapeutics management to meet with Needham
PremiumThe Fly
Stoke Therapeutics management to meet with Needham
7M ago
STOK
Stoke Therapeutics files to sell 10.84M shares of common stock for holders
PremiumThe Fly
Stoke Therapeutics files to sell 10.84M shares of common stock for holders
7M ago
STOK
Stoke Therapeutics price target lowered to $20 from $21 at Canaccord
PremiumThe FlyStoke Therapeutics price target lowered to $20 from $21 at Canaccord
9M ago
STOK
Stoke Therapeutics reports Q1 EPS (57c), consensus (61c)
Premium
The Fly
Stoke Therapeutics reports Q1 EPS (57c), consensus (61c)
9M ago
STOK
Stoke Therapeutics CFO Stephen Tulipano to resign, Thomas Leggett to succeed
Premium
The Fly
Stoke Therapeutics CFO Stephen Tulipano to resign, Thomas Leggett to succeed
9M ago
STOK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >